Relaxin/insulin-like family peptide receptor 4 (Rxfp4) expressing hypothalamic neurons modulate food intake and preference in mice

被引:12
|
作者
Lewis, Jo E. [1 ]
Woodward, Orla RM. [1 ]
Nuzzaci, Danae [1 ]
Smith, Christopher A. [1 ]
Adriaenssens, Alice E. [1 ]
Billing, Lawrence [1 ]
Brighton, Cheryl [1 ]
Phillips, Benjamin U. [2 ]
Tadross, John A. [1 ,3 ]
Kinston, Sarah J. [4 ]
Ciabatti, Ernesto [4 ]
Goettgens, Berthold [4 ]
Tripodi, Marco [5 ]
Hornigold, David [6 ]
Baker, David [6 ]
Gribble, Fiona M. [1 ]
Reimann, Frank [1 ]
机构
[1] Addenbrookes Hosp, Wellcome Trust MRC Inst Metab Sci Metab Res Labs, Hills Rd, Cambridge CB20QQ, England
[2] Univ Cambridge, Dept Physiol, Dev & Neurosci, Cambridge, England
[3] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England
[4] Univ Cambridge, Wellcome & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge, England
[5] Neurobiol Div, MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England
[6] AstraZeneca Ltd, Res & Early Dev Cardiovasc, Renal & Metab CVRM, BioPharmaceut R&D, Cambridge, England
来源
MOLECULAR METABOLISM | 2022年 / 66卷
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
RXFP4; Insl5; CNS; VMH; Food intake; VENTROMEDIAL HYPOTHALAMUS; BODY-WEIGHT; FEEDING-BEHAVIOR; IN-VIVO; RELAXIN-3; ENERGY; NUCLEUS; INSL5; IDENTIFICATION; GPCR142;
D O I
10.1016/j.molmet.2022.101604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Insulin-like peptide 5 (INSL5) signalling, through its cognate receptor relaxin/insulin-like family peptide receptor 4 (RXFP4), has been reported to be orexigenic, and the high fat diet (HFD) preference observed in wildtype mice is altered in Rxfp4 knock-out mice. In this study, we used a new Rxfp4-Cre mouse model to investigate the mechanisms underlying these observations. Methods: We generated transgenic Rxfp4-Cre mice and investigated central expression of Rxfp4 by RT-qPCR, RNAscope and intraparenchymal infusion of INSL5. Rxfp4-expressing cells were chemogenetically manipulated in global Cre-reporter mice using designer receptors exclusively activated by designer drugs (DREADDs) or after stereotactic injection of a Cre-dependent AAV-DIO-Dq-DREADD targeting a population located in the ventromedial hypothalamus (RXFP4(VMH)). Food intake and feeding motivation were assessed in the presence and absence of a DREADD agonist. Rxfp4-expressing cells in the hypothalamus were characterised by single-cell RNA-sequencing (scRNAseq) and the connectivity of RXFP4(VMH) cells was investigated using viral tracing. Results: Rxfp4-Cre mice displayed Cre-reporter expression in the hypothalamus. Active expression of Rxfp4 in the adult mouse brain was confirmed by RT-qPCR and RNAscope. Functional receptor expression was supported by cyclic AMP-responses to INSL5 application in ex vivo brain slices and increased HFD and highly palatable liquid meal (HPM), but not chow, intake after intra-VMH INSL5 infusion. scRNAseq of hypothalamic RXFP4 neurons defined a cluster expressing VMH markers, alongside known appetite-modulating neuropeptide receptors (Mc4r, Cckar and Nmur2). Viral tracing demonstrated RXFP4(VMH) neural projections to nuclei implicated in hedonic feeding behaviour. Whole body chemogenetic inhibition (Di-DREADD) of Rxfp4-expressing cells, mimicking physiological INSL5-RXFP4 Gi-signalling, increased intake of the HFD and HPM, but not chow, whilst activation (Dq-DREADD), either at whole body level or specifically within the VMH, reduced HFD and HPM intake and motivation to work for the HPM. Conclusion: These findings identify RXFP4(VMH) neurons as regulators of food intake and preference, and hypothalamic RXFP4 signalling as a target for feeding behaviour manipulation. (C) 2022 The Authors. Published by Elsevier GmbH.
引用
收藏
页数:18
相关论文
共 44 条
  • [1] Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor
    Ang, Sheng Y.
    Hutchinson, Dana S.
    Patil, Nitin
    Evans, Bronwyn A.
    Bathgate, Ross A. D.
    Halls, Michelle L.
    Hossain, Mohammed A.
    Summers, Roger J.
    Kocan, Martina
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (10) : 1077 - 1089
  • [2] Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4)
    Chen, Yan
    Zhou, Qingtong
    Wang, Jiang
    Xu, Youwei
    Wang, Yun
    Yan, Jiahui
    Wang, Yibing
    Zhu, Qi
    Zhao, Fenghui
    Li, Chenghao
    Chen, Chuan-Wei
    Cai, Xiaoqing
    Bathgate, Ross A. . D.
    Shen, Chun
    Eric Xu, H.
    Yang, Dehua
    Liu, Hong
    Wang, Ming-Wei
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [3] Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4)
    Yan Chen
    Qingtong Zhou
    Jiang Wang
    Youwei Xu
    Yun Wang
    Jiahui Yan
    Yibing Wang
    Qi Zhu
    Fenghui Zhao
    Chenghao Li
    Chuan-Wei Chen
    Xiaoqing Cai
    Ross A .D. Bathgate
    Chun Shen
    H. Eric Xu
    Dehua Yang
    Hong Liu
    Ming-Wei Wang
    Nature Communications, 14
  • [4] Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor (vol 174, pg 1077, 2017)
    Ang, S. Y.
    Hutchinson, D. S.
    Patil, N.
    Evans, B. A.
    Rad, Bathgate
    Halls, M. L.
    Hossain, M. A.
    Summers, R. J.
    Kocan, M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (24) : 4836 - 4836
  • [5] The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4
    Sheng Y. Ang
    Dana S. Hutchinson
    Bronwyn A. Evans
    Mohammed A. Hossain
    Nitin Patil
    Ross A. D. Bathgate
    Martina Kocan
    Roger J. Summers
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2017, 390 : 105 - 111
  • [6] The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4
    Ang, Sheng Y.
    Hutchinson, Dana S.
    Evans, Bronwyn A.
    Hossain, Mohammed A.
    Patil, Nitin
    Bathgate, Ross A. D.
    Kocan, Martina
    Summers, Roger J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 (01) : 105 - 111
  • [7] Colokinetic effect of an insulin-like peptide 5-related agonist of the RXFP4 receptor
    Diwakarla, Shanti
    Bathgate, Ross A. D.
    Zhang, Xiaozhou
    Hossain, Mohammed Akhter
    Furness, John B.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32 (05):
  • [8] Identification of important residues of insulin-like peptide 5 and its receptor RXFP4 for ligand-receptor interactions
    Wang, Xin-Yi
    Guo, Yu-Qi
    Shao, Xiao-Xia
    Liu, Ya-Li
    Xu, Zeng-Guang
    Guo, Zhan-Yun
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2014, 558 : 127 - 132
  • [9] Interaction mechanism of insulin-like peptide 5 with relaxin family peptide receptor 4
    Hu, Meng-Jun
    Wei, Dian
    Shao, Xiao-Xia
    Wang, Jia-Hui
    Liu, Ya-Li
    Xu, Zeng-Guang
    Guo, Zhan-Yun
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2017, 619 : 27 - 34
  • [10] Developing insulin-like peptide 5-based antagonists for the G protein-coupled receptor, RXFP4
    Wu, Hongkang
    Handley, Thomas N. G.
    Hoare, Bradley L.
    Hartono, Herodion A.
    Scott, Daniel J.
    Chalmers, David K.
    Bathgate, Ross A. D.
    Hossain, Mohammed Akhter
    BIOCHEMICAL PHARMACOLOGY, 2024, 224